Patent ductus arteriosus (PDA) treatment in premature infants
Not Applicable
Completed
- Conditions
- Patent ductus arteriosus (PDA)Circulatory System
- Registration Number
- ISRCTN12302923
- Lead Sponsor
- niversity of Jordan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
1. Premature infants born 32 weeks gestation or earlier
2. Newborns with birth weight 1500 g or under
Exclusion Criteria
1. Ductal dependent congenital heart diseases
2. Major congenital malformation
3. Grade 3-4 intraventricular hemorrhage
4. Renal impairment defined as Creatinine > 1.5 mg/dl
5. Pulmonary hemorrhage
6. Thrombocytopenia < 60.000 /mm 3
7. Elevated Alanine transaminase (ALT)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method